SynthesisCancer reports (Hoboken, N.J.)2022

EGFR-plasma mutations in prognosis for non-small cell lung cancer treated with EGFR TKIs: A meta-analysis.

Thang Thanh Phan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.